![](/images/general/no_picture/200_user.png)
Hoa T Le
Examiner (ID: 13075, Phone: (571)272-1511 , Office: P/1788 )
Most Active Art Unit | 1788 |
Art Unit(s) | 1794, 1787, 1316, 2899, 1773, 1788, 1509, 1709 |
Total Applications | 2557 |
Issued Applications | 1900 |
Pending Applications | 185 |
Abandoned Applications | 471 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16762372
[patent_doc_number] => 20210107953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => ACTIVE POLYPEPTIDE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/727078
[patent_app_country] => US
[patent_app_date] => 2019-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16727078
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/727078 | ACTIVE POLYPEPTIDE COMPOUND | Dec 25, 2019 | Abandoned |
Array
(
[id] => 16451036
[patent_doc_number] => 20200360462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH
[patent_app_type] => utility
[patent_app_number] => 16/724076
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -93
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/724076 | METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH | Dec 19, 2019 | Abandoned |
Array
(
[id] => 17426880
[patent_doc_number] => 20220054588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => USE OF SAP FOR THE TREATMENT OF EUROTIOMYCETES FUNGI INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/415332
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415332
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/415332 | USE OF SAP FOR THE TREATMENT OF EUROTIOMYCETES FUNGI INFECTIONS | Dec 17, 2019 | Pending |
Array
(
[id] => 18887708
[patent_doc_number] => 11866469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => DNA binding proteins and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/287218
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 9
[patent_no_of_words] => 37384
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287218
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287218 | DNA binding proteins and uses thereof | Dec 15, 2019 | Issued |
Array
(
[id] => 17385618
[patent_doc_number] => 20220033470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Compositions Comprising Sortilin-1
[patent_app_type] => utility
[patent_app_number] => 17/413184
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17413184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/413184 | Compositions Comprising Sortilin-1 | Dec 12, 2019 | Pending |
Array
(
[id] => 17272036
[patent_doc_number] => 20210378234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => ANTI-FREEZING COMPOSITION COMPRISING SELF-ASSEMBLY COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/973494
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16973494
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/973494 | ANTI-FREEZING COMPOSITION COMPRISING SELF-ASSEMBLY COMPOUND | Dec 11, 2019 | Pending |
Array
(
[id] => 16053247
[patent_doc_number] => 20200188478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => PRE-MIXED, READY TO USE VANCOMYCIN COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/712079
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712079
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712079 | PRE-MIXED, READY TO USE VANCOMYCIN COMPOSITIONS | Dec 11, 2019 | Abandoned |
Array
(
[id] => 15738481
[patent_doc_number] => 20200108128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => TREATMENT OF ABNORMAL CUTANEOUS SCARRING
[patent_app_type] => utility
[patent_app_number] => 16/710387
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710387
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/710387 | Treatment of abnormal cutaneous scarring | Dec 10, 2019 | Issued |
Array
(
[id] => 15741085
[patent_doc_number] => 20200109430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => COMPOSITIONS FOR IN SITU LABELING OF BACTERIAL CELL WALLS WITH FLUOROPHORES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/706592
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16706592
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/706592 | COMPOSITIONS FOR IN SITU LABELING OF BACTERIAL CELL WALLS WITH FLUOROPHORES AND METHODS OF USE THEREOF | Dec 5, 2019 | Pending |
Array
(
[id] => 17443727
[patent_doc_number] => 20220064232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS OF SEPARATING PHOSVITIN AND HDL FROM AN EGG YOLK PRODUCT AND RESULTING COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/311664
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/311664 | METHODS OF SEPARATING PHOSVITIN AND HDL FROM AN EGG YOLK PRODUCT AND RESULTING COMPOSITIONS | Dec 4, 2019 | Pending |
Array
(
[id] => 17221808
[patent_doc_number] => 11174299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Peptides and compositions for prevention of cell adhesion and methods of using same
[patent_app_type] => utility
[patent_app_number] => 16/704849
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9658
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16704849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/704849 | Peptides and compositions for prevention of cell adhesion and methods of using same | Dec 4, 2019 | Issued |
Array
(
[id] => 18517635
[patent_doc_number] => 11707505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => VCP and factor H as viral entry inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/684630
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 10750
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16684630
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/684630 | VCP and factor H as viral entry inhibitors | Nov 14, 2019 | Issued |
Array
(
[id] => 15931023
[patent_doc_number] => 20200157145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => NEUTRAL-CATIONIC PEPTOIDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/685604
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16685604
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/685604 | NEUTRAL-CATIONIC PEPTOIDS AND USES THEREOF | Nov 14, 2019 | Abandoned |
Array
(
[id] => 17399566
[patent_doc_number] => 20220041656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => NOVEL COMPOUND AND ANGIOGENIC AGENT COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 17/299035
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299035
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299035 | NOVEL COMPOUND AND ANGIOGENIC AGENT COMPRISING SAME | Oct 30, 2019 | Pending |
Array
(
[id] => 16806127
[patent_doc_number] => 20210128680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => METHOD FOR TREATING CARDIOPULMONARY DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/669495
[patent_app_country] => US
[patent_app_date] => 2019-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16669495
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/669495 | METHOD FOR TREATING CARDIOPULMONARY DISORDER | Oct 29, 2019 | Pending |
Array
(
[id] => 17272961
[patent_doc_number] => 20210379159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => STABLE SEMAGLUTIDE COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/288128
[patent_app_country] => US
[patent_app_date] => 2019-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288128
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/288128 | STABLE SEMAGLUTIDE COMPOSITIONS AND USES THEREOF | Oct 24, 2019 | Pending |
Array
(
[id] => 15828607
[patent_doc_number] => 20200129585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => ADIPONECTIN PEPTIDOMIMETICS FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/662932
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16662932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/662932 | ADIPONECTIN PEPTIDOMIMETICS FORMULATIONS | Oct 23, 2019 | Pending |
Array
(
[id] => 17334635
[patent_doc_number] => 20220000966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => COMPOSITION AND METHOD FOR TREATING THE LUNGS
[patent_app_type] => utility
[patent_app_number] => 17/287766
[patent_app_country] => US
[patent_app_date] => 2019-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287766
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287766 | COMPOSITION AND METHOD FOR TREATING THE LUNGS | Oct 22, 2019 | Pending |
Array
(
[id] => 18202397
[patent_doc_number] => 11584779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Solid state forms of voclosporin
[patent_app_type] => utility
[patent_app_number] => 17/286542
[patent_app_country] => US
[patent_app_date] => 2019-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6175
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17286542
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/286542 | Solid state forms of voclosporin | Oct 20, 2019 | Issued |
Array
(
[id] => 18168624
[patent_doc_number] => 20230035235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => SWI/SNF FAMILY CHROMATIN REMODELING COMPLEXES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/283804
[patent_app_country] => US
[patent_app_date] => 2019-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 303506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -60
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/283804 | SWI/SNF FAMILY CHROMATIN REMODELING COMPLEXES AND USES THEREOF | Oct 14, 2019 | Pending |